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Diet-induced obesity mediated by the
JNK/DIO2 signal transduction pathway
Santiago Vernia,1 Julie Cavanagh-Kyros,1,2 Tamera Barrett,1,2 Dae Young Jung,1 Jason K. Kim,1,3
and Roger J. Davis1,2,4
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA; 2Howard
Hughes Medical Institute, Worcester, Massachusetts 01605, USA; 3Department of Medicine, Division of Endocrinology,
Metabolism, and Diabetes, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
The cJun N-terminal kinase (JNK) signaling pathway is a key mediator of metabolic stress responses caused by
consuming a high-fat diet, including the development of obesity. To test the role of JNK, we examined diet-
induced obesity in mice with targeted ablation of Jnk genes in the anterior pituitary gland. These mice exhibited
an increase in the pituitary expression of thyroid-stimulating hormone (TSH), an increase in the blood
concentration of thyroid hormone (T4), increased energy expenditure, and markedly reduced obesity compared
with control mice. The increased amount of pituitary TSH was caused by reduced expression of type 2
iodothyronine deiodinase (Dio2), a gene that is required for T4-mediated negative feedback regulation of TSH
expression. These data establish a molecular mechanism that accounts for the regulation of energy expenditure
and the development of obesity by the JNK signaling pathway.
[Keywords: DIO2; JNK; obesity; pituitary gland; thyroid hormone]
Supplemental material is available for this article.
Received June 5, 2013; revised version accepted October 3, 2013.
Human obesity is a serious health problem that is as-
sociated with increased mortality arising from a number
of complications, including cardiovascular and kidney
disease, diabetes, and some forms of cancer (Flegal et al.
2013). It is therefore alarming that the worldwide in-
cidence of human obesity is rapidly increasing (World
Health Organization Consultation on Obesity 2000). The
design of potential therapeutic interventions to address
this problem requires knowledge of the molecular mech-
anisms that contribute to obesity.
The cJun N-terminal kinase signaling (JNK) pathway
(Davis 2000) is implicated in the development of obesity
(Sabio and Davis 2010). Indeed, obesity is associated with
increased JNK activity in human omental adipose tissue
(Bashan et al. 2007). Obesity-induced JNK activation is
mediated, in part, by free fatty acids (FFAs) that activate
the mixed-lineage protein kinase pathway (Jaeschke and
Davis 2007; Gadang et al. 2013; Kant et al. 2013). The
mechanism of FFA signaling may involve G-protein-
coupled receptors (Talukdar et al. 2011) or nonreceptor
mechanisms (Holzer et al. 2011) that cause activation of
the tyrosine kinase Src in lipid raft domains of the plasma
membrane (Holzer et al. 2011).
Hyperphagic and high-fat diet (HFD) models of obesity
in mice demonstrate activation of the JNK pathway
(Hirosumi et al. 2002). Importantly, JNK deficiency pre-
vents the development of obesity in these mouse models
(Hirosumi et al. 2002). Tissue-specific gene ablation stud-
ies indicate that JNK in peripheral tissues (adipose tissue,
liver, muscle, and myeloid cells) does not influence
obesity development (Sabio et al. 2008, 2009, 2010b; Han
et al. 2013). In contrast, a central function of JNK is re-
quired for obesity development (Sabio and Davis 2010).
Studies using mice with Nestin-cre-mediated ablation of
floxed Jnk1 in the brain demonstrate that JNK deficiency
causes increased energy expenditure that prevents obesity
(Belgardt et al. 2010; Sabio et al. 2010a). This analysis in-
dicates that JNK-mediated suppression of energy expendi-
ture is critically required for obesity development (Sabio
and Davis 2010).
The mechanism of JNK-mediated regulation of energy
expenditure is unclear. The hypothalamic–pituitary–thy-
roid (HPT) hormone axis has been implicated in the JNK-
mediated energy expenditure response (Sabio and Davis
2010). However, relevant molecular targets of the JNK
signaling pathway have not been described. Here we
identify the type 2 iodothyronine deiodinase (Dio2) gene
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as a target of JNK signaling that negatively regulates the
HPT axis. We show that consuming a HFD causes JNK
activation, increasedDio2 gene expression, and decreased
HPT axis-mediated energy expenditure. JNK inhibition
prevents DIO2-mediated negative feedback regulation of
the HPT axis, increases energy expenditure, and reduces
obesity. Together, these data identify the Dio2 gene as a
critical target of the JNK signaling pathway that regulates
energy expenditure and obesity.
Results
The pituitary gland is an essential component of the
endocrine axis that regulates thyroid hormone signaling
because it is the source of thyroid-stimulating hormone
(TSH), a glycoprotein hormone that regulates the endo-
crine function of the thyroid gland. The potential role of
the pituitary gland in JNK-mediated obesity development
is intriguing. To test JNK function, we established mice
with targeted ablation of the ubiquitously expressed Jnk1
and Jnk2 genes using the glycoprotein hormone a subunit
(Cga) promoter to drive expression of Cre recombinase in
the anterior pituitary gland. Genotype analysis demon-
strated ablation of the Jnk1 and Jnk2 genes in the anterior
pituitary gland of Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP mice
(PDJ1,J2 mice) (Supplemental Fig. S1). No defects in JNK
expression in other tissues were detected (Supplemental
Fig. S1). Microscopic examination of the pituitary gland
demonstrated that JNK deficiency did not cause marked
changes in morphology (Fig. 1A; Supplemental Fig. S2).
Feeding a HFD to control mice (PWT mice) caused robust
activation of JNK in the anterior pituitary gland but not in
PDJ1,J2 mice (Fig. 1B). These data establish that PDJ1,J2 mice
represent amodel that can be used to test the role of HFD-
induced JNK activation in the anterior pituitary gland.
JNK in the anterior pituitary gland promotes obesity
and insulin resistance
We examined the body mass of PWTand PDJ1,J2 mice when
fed a normal chow diet (ND) or a HFD for 16 wk. No
significant difference in total body mass was detected in
ND-fed mice, but the JNK-deficient mice exhibited
markedly decreased body mass compared with PWT mice
when fed a HFD (Fig. 1C). These changes in body mass
were not associated with changes in body length (Supple-
mental Fig. 1B). The decreased body mass was largely
accounted for by reduced fat mass (Fig. 1D). Adipokine
expression (Supplemental Fig. S3B), adipocyte hypertro-
phy (Fig. 1E; Supplemental Fig. S3A), and adipose tissue
Figure 1. JNK in the anterior pituitary gland is
required for HFD-induced obesity. (A) The mor-
phology of the pituitary gland of PWT and PDJ1,J2
mice was examined by scanning electron micros-
copy. Bar, 500 mm. (B) Sections of the anterior
pituitary gland of PWT and PDJ1,J2 mice were
stained with an antibody to phosphoJNK. DNA
was stained with DAPI. The effect of feeding mice
an ND or a HFD for 16 wk was examined. Bar, 50
mm. (C) The total body mass gain of ND-fed and
HFD-fed mice was examined (mean 6 SEM; n =
10;25). Significant differences between PWT and
PDJ1,J2 mice were detected. (***) P < 0.001. (D) The
fat and lean mass of ND-fed and HFD-fed (16 wk)
mice were measured by 1H-MRS analysis (mean 6
SEM; n = 8;10). Significant differences between
PWT and PDJ1,J2 mice were detected. (*) P < 0.05.
(E,F) Sections of epididymal adipose tissue of ND-
fed and HFD-fed (16 wk) mice were stained with
hematoxylin and eosin (E) or an antibody to
the macrophage marker F4/80 plus DAPI (F). Bar,
125 mm.
Vernia et al.
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infiltration by macrophages (Fig. 1E,F; Supplemental Fig.
S3C) were suppressed in HFD-fed PDJ1,J2 mice compared
with HFD-fed PWT mice. JNK deficiency in the anterior
pituitary gland also suppressed HFD-induced hepatic
steatosis (Supplemental Fig. S4) and brown fat cell hyper-
trophy (Fig. 2A). Indeed, brown fat mass in HFD-fed mice
was significantly reduced in PDJ1,J2 mice compared with
PWT mice (Fig. 2B). Together, these data implicate HFD-
induced JNK activation in the anterior pituitary gland
(Fig. 1B) as a signaling mechanism that controls the de-
velopment of obesity (Fig. 1C).
Obesity is a major contributor to the development of
prediabetes, including impaired glycemia and insulin
resistance (Kahn et al. 2006). We therefore anticipated
that defects in obesity would lead to improved glucose
metabolism in PDJ1,J2 mice. Indeed, PDJ1,J2 mice showed
improved glucose and insulin tolerance (Fig. 3A,B), re-
duced hyperglycemia (Fig. 3C,D), reduced hyperinsuline-
mia (Fig. 3E), and reduced islet hypertrophy (Fig. 3F,G)
compared with PWT mice. Moreover, the HFD-fed PDJ1,J2
mice showed improved insulin-stimulated AKT activa-
tion in adipose tissue, liver, and skeletal muscle (Fig. 3H).
It is likely that these phenotypes are a consequence of the
reduced obesity of PDJ1,J2 mice compared with PWT mice
(Fig. 1).
Pituitary gland JNK decreases energy expenditure
and promotes obesity
We performed metabolic cage analysis to examine mech-
anisms that might account for the reduced obesity of
HFD-fed PDJ1,J2 mice compared with PWT mice. These
studies demonstrated that the physical activity and the
amount of food eaten by PWT and PDJ1,J2 mice were sim-
ilar, but energy expenditure by HFD-fed PDJ1,J2 mice was
significantly greater than that of HFD-fed PWT mice (Fig.
4). These data indicate that increased energy expenditure
is a major contributor to the resistance of PDJ1,J2 mice to
HFD-induced obesity.
The JNK1 and JNK2 isoforms exhibit partial
functional redundancy
To examine the relative contributions of the JNK1 and
JNK2 isoforms, we investigated the effect of feeding a
HFD to mice with ablation of Jnk1 or Jnk2 only (PDJ1 and
PDJ2 mice) in the anterior pituitary gland. This analysis
demonstrated that HFD-fed PDJ1 mice, PDJ2 mice, and PWT
mice exhibited similar HFD-induced obesity, glucose and
insulin tolerance, energy expenditure, and food consump-
tion (Supplemental Figs. S5, S6). These data contrast with
studies of PDJ1,J2 mice (Figs. 1–3) and indicate that JNK1
and JNK2 play partially redundant roles in the anterior
pituitary gland.
JNK regulates the expression of pituitary hormones
A major function of the anterior pituitary gland is the
production of hormones that regulate metabolism and
reproduction. The blood concentration of growth hor-
mone (GH) and adrenocorticotrophic hormone (ACTH;
a component of the pituitary–adrenal axis) was similar in
PWT and PDJ1,J2 mice, but a modest increase in the blood
concentration of the reproductive hormones follicle-
stimulating hormone (FSH) and luteinizing hormone
(LH) was detected in the blood of PDJ1,J2 mice compared
with PWT mice (Supplemental Fig. S7). The relevance of
these changes to the development of obesity is unclear.
However, the increased blood concentration of TSH in
PDJ1,J2 mice compared with PWT mice (Fig. 5A) may
contribute to the resistance of PDJ1,J2 mice to HFD-induced
obesity.
We found increased amounts of TSH (Fig. 5B) and
increased expression of Tshb mRNA [but not Cga (Tsha)
mRNA] in the anterior pituitary gland of PDJ1,J2 mice
compared with PWTmice (Fig. 5C). The increased amount
of blood TSH (Fig. 5A) was associated with an increased
concentration of thyroid hormone (T3 and T4) in the
blood of HFD-fed PDJ1,J2 mice compared with HFD-fed
PWT mice (Fig. 5A). Indeed, increased thyroid hormone-
dependent gene expression was detected in the liver and
brown adipose tissue of PDJ1,J2 mice compared with PWT
mice (Fig. 2C; Supplemental Fig. S4D). Together, these
data indicate that JNK deficiency in the pituitary gland
increases the thyroid hormone signaling axis.
Thyroid hormone mediates the effects of pituitary
JNK deficiency on obesity
To test the role of thyroid hormone on the resistance of
PDJ1,J2 mice to HFD-induced obesity (Fig. 1), we examined
the effect of propylthiouracil (PTU), a drug that inhibits
Figure 2. JNK in the anterior pituitary gland pro-
motes HFD-induced hypertrophy of brown adipose
tissue. (A) PWT and PDJ1,J2 mice were fed an ND or
a HFD (16 wk). Sections of interscapular brown
adipose tissue were stained with hematoxylin and
eosin. Bar, 125 mm. (B) Total interscapular brown
adipose tissue mass was measured (mean6 SEM; n =
14;20). (***) P < 0.001. (C) The expression of Spot14
and Glut4 mRNA in brown adipose tissue was
measured by quantitative RT–PCR assays (mean 6
SEM; n = 10;12). (*) P < 0.05.
JNK signaling promotes obesity
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thyroperoxidase and reduces thyroid hormone produc-
tion by the thyroid gland (Bjo¨rkman and Ekholm 2000).
Treatment of mice with PTU reduced the circulating
concentration of T4 (Supplemental Fig. S8). No signifi-
cant differences in blood T4 concentration were detected
between PTU-treated PWT and PDJ1,J2 mice (Supplemental
Fig. S8). We found that PTU prevented the resistance of
PDJ1,J2 mice to HFD-induced obesity (Fig. 6A,B) and also
prevented the improved hyperglycemia and glucose tol-
erance of HFD-fed PDJ1,J2 mice (Figs. 6C,D). These data
indicate that the thyroid hormone pathway is required for
the resistance of PDJ1,J2 mice to HFD-induced obesity.
Pituitary JNK deficiency promotes TSH expression
The increase in Tshb expression detected in JNK-deficient
pituitary glands could be mediated by increased positive
regulation or by decreased negative regulation. We there-
fore examined changes in positive and negative regulation
of Tshb expression in PWT and PDJ1,J2 mice.
Tshb expression is positively regulated by the tran-
scription factors Gata2 and Pou1f1 and negatively regu-
lated by the thyroid hormone receptor Thrb (Gordon et al.
1997; Abel et al. 1999). Comparison of the anterior pituitary
glands of PWT and PDJ1,J2 mice demonstrated no signifi-
cant differences in the expression of the Gata2, Pou1f1,
and Thrb transcription factors (Supplemental Fig. S9),
although we cannot exclude the possibility that JNK alters
the activity of one or more of these transcription factors.
Tshb expression is also positively regulated by hypotha-
lamic expression of thyrotropin-releasing hormone (TRH)
that binds receptors (TRHR) on thyrotrophs. No signifi-
cant difference in the anterior pituitary expression of Trhr
was detected between PWT and PDJ1,J2 mice (Supplemental
Fig. S9). Similarly, hypothalamic expression of Trh was
unchanged in chow-fed PWT and PDJ1,J2 mice but was
decreased in HFD-fed PDJ1,J2 mice compared with HFD-
fed PWT mice (Supplemental Fig. S10). This reduction in
hypothalamic Trh expression may reflect negative feed-
back regulation (Segerson et al. 1987) by the increased
concentration of circulating T4 detected in HFD-fed PDJ1,J2
mice compared with HFD-fed PWT mice (Fig. 5A). In
addition, the reduced blood leptin concentration in HFD-
fed PDJ1,J2 mice (Supplemental Fig. S3B) may also contrib-
ute to the decreased hypothalamic Trh expression (Nillni
et al. 2000; Guo et al. 2004; Perello et al. 2010). Together,
these data do not provide evidence for increased positive
regulation of Tshb expression in HFD-fed PDJ1,J2 mice.
Figure 3. JNK-mediated obesity causes in-
sulin resistance. (A,B) The effect of consum-
ing a HFD (16 wk) on glucose tolerance (A)
and insulin tolerance (B) was examined
(mean 6 SEM; n = 8;12). Significant differ-
ences between PWT and PDJ1,J2 mice were
detected. (*) P < 0.05; (**) P < 0.01; (***) P <
0.001. (C,D) The blood glucose concentra-
tion in mice fasted overnight (C) or fed ad
libitum (D) was measured (mean6 SEM; n =
20). (*) P < 0.05; (**) P < 0.01. (E) The blood
insulin concentration in mice fasted over-
night was measured (mean 6 SEM; n = 20).
(**) P < 0.01. (F,G) Sections of the pancreas
of PWT and PDJ1,J2 mice fed an ND or a HFD
(16 wk) were stained with an antibody to
insulin. DNA was stained with DAPI (blue).
Bar, 150 mm. The relative area of islets in pan-
creatic sections is presented as the mean 6
SEM (n = 25;35). (**) P < 0.01. (H) Mice
were starved overnight and treated by in-
traperitoneal injection with saline (control)
or insulin (1.5 U/kg). (Top panels) Tissue
extracts prepared at 15 min post-injection
were examined by multiplexed ELISA for
pAKT and AKT (mean 6 SEM; n = 5;6). (*)
P < 0.05. Representative extracts were also
examined by immunoblot analysis using
antibodies to aTubulin (Tub.), AKT, and
phospho-AKT (pSer473 and pThr308).
Vernia et al.
2348 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on May 1, 2014 - Published by genesdev.cshlp.orgDownloaded from 
Reduced negative regulation represents a potential
mechanism that contributes to increased TSH expression
detected in PDJ1,J2 mice compared with PWTmice. Amajor
mechanism of negative regulation of Tshb expression in
the pituitary gland is mediated by T3 (Silva and Larsen
1977). The bioavailability of T3 is critically controlled by
the thyroid hormone transporter Slc16A2 (Visser et al.
2011) and Dio genes (Bianco and Larsen 2005). Indeed,
Dio2 is critically required for prohormone T4 conversion
to biologically active T3 (Bianco and Kim 2006), andDio3
plays a key role in signal termination by converting T3 to
inactive reverse T3 (Bianco and Larsen 2005). Increased
Tshb expression by PDJ1,J2 mice may therefore be caused
by increased expression of Dio3 or reduced expression of
Slc16A2 or Dio2. However, a comparison of PWT and
PDJ1,J2 mice demonstrated no significant differences in
the expression of Slc16A2, Dio1, and Dio3, but JNK
deficiency caused markedly reduced Dio2 gene expres-
sion (Figs. 5C, 7A). These data indicate that Dio2 may
contribute to the effects of JNK on TSH expression by
thyrotrophs.
JNK regulates Dio2 gene expression
Dio2 gene expression is induced by activating protein 1
(AP1) transcription factors (Canettieri et al. 2008). This is
Figure 4. JNK suppresses energy expenditure. (A–D)
Metabolic cage analysis of HFD-fed (4 wk) PWT and
PDJ1,J2 mice was performed to measure energy expendi-
ture (A), physical activity (B), oxygen consumption
(VO2) (C), and carbon dioxide release (VCO2) (D). The
data presented are the mean 6 SEM (n = 6), and the
statistical significance of differences is indicated. (E–G)
ND-fed and HFD-fed (4 wk) PWT and PDJ1,J2 mice were
examined in metabolic cages to measure food intake
(E), water intake (F), and the respiratory exchange ratio
(VCO2/VO2) (G). The data presented are the mean 6
SEM (n = 6). No statistically significant differences
between PWT and PDJ1,J2 mice were detected.
Figure 5. JNK deficiency causes increased TSH
expression. (A) The blood concentration of TSH,
T3, T4, and free T4 in ND-fed and HFD-fed (4
wk) PWT and PDJ1,J2 mice following overnight
starvation was measured by ELISA (mean 6
SEM; n = 8;12). (*) P < 0.05. (B) Sections of the
pituitary gland were stained with an antibody to
TSHb. DNA was stained with DAPI. The ante-
rior lobe (AL) and posterior lobe (PL) of the
pituitary gland are indicated. (C) Total RNA
was isolated from primary cultures of pituitary
cells isolated from control and JNK-deficient
mice. Gene expression was measured by quanti-
tative RT–PCR analysis of mRNA (mean 6 SEM;
n = 6;8). (*) P < 0.05; (**) P < 0.01.
JNK signaling promotes obesity
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significant because AP1 expression and function are
direct targets of the JNK signaling pathway (Davis 2000).
We therefore examined AP1 expression in the pituitary
gland of PWTand PDJ1,J2 mice. JNK deficiency was found to
cause reduced expression of the AP1 transcription factors
cJun and JunD (Fig. 7C,D). This reduced AP1 expression
was associated with decreasedDio2 gene expression in the
anterior pituitary gland of PDJ1,J2 mice compared with PWT
mice (Fig. 7C). Moreover, tumor necrosis factor (TNF),
a JNK-dependent activator of AP1 (Ventura et al. 2003),
strongly induces Dio2 gene expression (Baur et al. 2000)
in thyrotrophs of PWT mice but not PDJ1,J2 mice (Fig. 7B).
Together, these observations indicate that the JNK path-
way, activated by consuming a HFD (Fig. 1B), regulates
Dio2 gene expression in the anterior pituitary gland of
HFD-fed mice (Fig. 7A).
JNK deficiency in the anterior pituitary gland
mimics Dio2 deficiency
To test whether decreased Dio2 gene expression in the
anterior pituitary gland contributes to the phenotype of
PDJ1,J2 mice, we examined the effect of thyroid hormone
on negative regulation of TSH expression. It is established
that Dio2 gene ablation prevents T4-mediated inhibition
of TSH expression (Schneider et al. 2001). We therefore
investigated the effect of thyroid hormone on TSH ex-
pression by PWT and PDJ1,J2 mice. Control studies demon-
strated that T3 caused a similar small decrease in the
blood concentration of TSH in PWT and PDJ1,J2 mice (Fig.
8). In contrast, T4 strongly suppressed the amount of TSH
in the blood of PWT mice but not PDJ1,J2 mice (Fig. 8A).
Moreover, in vitro studies using primary anterior pitui-
tary cell cultures demonstrated that JNK deficiency
prevented T4-mediated repression of Tshb gene expression
(Fig. 8B). This defect in T4-mediated negative feedback
regulation of TSH expression caused by JNK deficiency is
similar to that found in Dio2-deficient mice (Schneider
et al. 2001). These data strongly support the conclusion
that JNK-regulated Dio2 gene expression mediates the
effects of JNK on TSH expression in the anterior pituitary
gland.
Discussion
The JNK signaling pathway is activated in response to
metabolic stress. Recent studies have demonstrated that
JNK activation caused by consuming a HFD contributes
to two different metabolic responses: the development of
insulin resistance and obesity (Sabio and Davis 2010).
These two responses represent separate targets of the JNK
signaling pathway. Thus, tissue-specific gene ablation
studies indicate that JNK in peripheral tissues is required
for HFD-induced insulin resistance but not obesity (Sabio
and Davis 2010). In contrast, a central function of JNK to
regulate energy expenditure is required for HFD-induced
obesity (Sabio and Davis 2010).
The effects of JNK on insulin resistance may be me-
diated by phosphorylation of target proteins, including
the insulin receptor adapter protein IRS1 (Aguirre et al.
2000). However, the mechanism of central JNK signaling
that regulates energy expenditure and obesity is unclear.
Studies of mice with JNK deficiency in the brain have
identified the HPT axis as a potential mediator of JNK
signaling (Belgardt et al. 2010; Sabio et al. 2010a). It was
found that JNK deficiency in the brain caused increased
energy expenditure that was dependent on the HPT axis
(Sabio and Davis 2010). However, themolecular targets of
JNK that mediate the effects of HFD-induced JNK acti-
vation on the HPT axis have not been defined.
Hypothalamic TRH acts on thyrotrophs in the anterior
pituitary gland that respond by secreting TSH, a glycopro-
tein hormone that stimulates the thyroid gland to in-
crease thyroid hormone production. In obese mice, the
adipokine leptin acts on the hypothalamus to increase
TRH-mediated TSH expression (Nillni et al. 2000; Perello
et al. 2010). TRH also promotes TSH glycosylation and
Figure 6. Thyroid hormone is required for glycemic regulation
caused by JNK deficiency in the pituitary gland. (A) The total
body mass gain of PTU-treated ND-fed and HFD-fed mice
treated with PTU in the drinking water was examined (mean 6
SEM; n = 7;10). No significant differences between PWT and
PDJ1,J2 mice were detected. P > 0.05. (B) The fat and lean mass of
PTU-treated ND-fed and HFD-fed (16 wk) mice were measured
by 1H-MRS analysis (mean 6 SD; n = 7;10). No significant
differences between PWTand PDJ1,J2 mice were detected. P > 0.05.
(C) The effect of consuming a HFD (16 wk) on glucose tolerance
of PTU-treated mice was examined (mean 6 SEM; n = 8;12).
No significant differences between PWT and PDJ1,J2 mice were
detected. P > 0.05. (D) PTU-treated PWT and PDJ1,J2 mice were fed
an ND or a HFD (16 wk). The blood glucose concentration in
mice fasted overnight or fed ad libitum was measured (mean 6
SEM; n = 7~12). P > 0.05.
Vernia et al.
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bioactivity (Weintraub et al. 1989; Magner 1990). The
resulting increase in thyroid hormone production is
limited by thyroid hormone-mediated feedback inhibi-
tion of TRH and TSH expression (Silva and Larsen 1977;
Segerson et al. 1987). The HPT axis is therefore subject
to complex regulatory control by neuronal innervation
together with hormones and adipokines. Indeed, regula-
tion of the HPT axis by diet-induced obesity may involve
changes in TRH expression, TSH expression and bio-
activity, and the amount of thyroid hormone in the blood.
To test JNK function in the anterior pituitary gland, we
established mice with targeted ablation of the ubiqui-
tously expressed Jnk1 and Jnk2 genes using the Cga
promoter to drive expression of Cre recombinase. The
PDJ1,J2 mice were found to be resistant to HFD-induced
obesity (Fig. 1). This reduced obesity was caused by in-
creased energy expenditure (Fig. 4) and was dependent on
the HPT axis (Fig. 6).
The discovery of increased TSH and thyroid hormone
in the blood of HFD-fed PDJ1,J2 mice compared with HFD-
fed PWT mice (Fig. 5) was surprising because it is estab-
lished that thyroid hormone causes profound negative
feedback regulation of both hypothalamic TRH and pi-
tuitary TSH production (Silva and Larsen 1977; Segerson
et al. 1987). TRH expression was reduced in HFD-fed
PDJ1,J2 mice compared with HFD-fed PWTmice, consistent
with negative feedback regulation by thyroid hormone
(Supplemental Fig. S10). However, TSH expression by
HFD-fed PDJ1,J2 mice was increased (compared with HFD-
fed PWT mice) despite reduced hypothalamic TRH ex-
pression (Supplemental Fig. S10) and increased amounts
of thyroid hormone in the blood (Fig. 5). This observation
suggests that the primary phenotype of HFD-fed PDJ1,J2
mice is failure of the negative regulation of TSH expres-
sion by thyroid hormone. Indeed, PDJ1,J2 mice were found
to be resistant to T4-mediated negative feedback regula-
tion of TSH production (Fig. 8). This defect in negative
regulation contributes to increased HPT axis function in
HFD-fed PDJ1,J2 mice compared with HFD-fed PWT mice.
It is established that the inhibition of TSH production
caused by thyroid hormone requires the DIO2-dependent
intracellular conversion of the prohormone T4 to biolog-
ically active T3 (Bianco and Kim 2006).Dio2 gene ablation
prevents T4-mediated inhibition of TSH expression
Figure 7. JNK promotes expression of Dio2
in the anterior pituitary gland. (A) PWT and
PDJ1,J2 mice were fed an ND or a HFD (16
wk). Total RNA was isolated from the
anterior pituitary gland, and the expression
of Dio (Dio1, Dio2, and Dio3) mRNA was
measured by quantitative RT–PCR assays
(mean 6 SEM, n = 7;12). (*) P < 0.05. (B)
Primary cultures of anterior pituitary gland
cells were treated without and with 10 ng/
mL TNFa (12 h). The expression of Dio2
mRNA was measured by quantitative RT–
PCR assays (mean 6 SEM; n = 6). (*) P <
0.05. (C) PWT and PDJ1,J2 mice were fed a
ND or a HFD (16 wk). Total RNA was
isolated from the anterior pituitary gland,
and the expression of AP-1 transcription
factor (cJun, JunB, JunD, and cFos) mRNA
was measured by quantitative RT–PCR as-
says (mean 6 SEM, n = 7;12). (*) P < 0.05.
(D) Extracts prepared from the anterior
pituitary gland of PWT and PDJ1,J2 mice were
examined by immunoblot analysis by prob-
ing with antibodies to cJun, JNK, and
aTubulin.
Figure 8. JNK is required for negative feedback regulation of
the pituitary gland by thyroid hormone. (A) PWT and PDJ1,J2 mice
were fed a HFD and treated with PTU in the drinking water (16
wk). The blood concentration of TSH was measured by ELISA.
The effect of intraperitoneal injection of solvent (control) or
thyroid hormone (30 mg/kg T3 or 10 mg/kg T4) was examined (5
h). The data presented show the decrease in blood TSH concen-
tration caused by treatment with thyroid hormone (mean 6
SEM; n = 10). (**) P < 0.01. (B) Primary cultures of anterior
pituitary cells were incubated (12 h) with vehicle (control) or T4
(25 nM). Tshb mRNA expression was measured by quantitative
RT–PCR analysis (mean 6 SEM; n = 8). (**) P < 0.01.
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(Schneider et al. 2001), and DIO2 deficiency in the
pituitary gland causes reduced obesity (Fonseca et al. 2013).
Dio2 therefore represents a potential JNK target gene that
mediates HPT axis regulation by JNK. Indeed, Dio2 gene
expression was reduced in the pituitary gland of HFD-fed
PDJ1,J2 mice compared with HFD-fed PWT mice (Fig. 7).
Collectively, these data indicate that JNK-promoted
obesity is mediated in part by HFD-induced JNK activa-
tion in the anterior pituitary gland, increased expression
of the JNK target gene Dio2, increased negative feedback
regulation of TSH production, and reduced energy expen-
diture. We cannot exclude the possibility that additional
JNK target genes play important roles. Other factors may
also contribute to the phenotype of PDJ1,J2 mice, including
changes in TRH-regulated TSH bioactivity. Moreover,
our analysis does not exclude contributing roles for
inflammatory cytokines, hormones, and adipokines. In-
deed, the reduced inflammation detected in PDJ1,J2 mice
(Fig. 1E,F; Supplemental Fig. S3) may contribute to
improved glycemia (Han et al. 2013). Altered inflamma-
tion may also influence thyroid gland function by chang-
ing the expression of thyrotropin, thyroperoxidase, and
the Na+/I symporter (Velez et al. 2006; Nicola et al. 2009;
Nazar et al. 2012). Nevertheless, our data establish that
Dio2 is a key JNK target gene in the anterior pituitary
gland that contributes to obesity.
We speculate that DIO2 may play a similar role in the
regulation of TRH expression by hypothalamic JNK (Sabio
and Davis 2010). Mice with JNK deficiency in the brain
exhibit increased hypothalamic TRH expression despite
increased amounts of thyroid hormone in the blood (Sabio
and Davis 2010). The T4-mediated negative feedback
pathway that represses neuronal TRH expression requires
nonneuronal cells that express DIO2, including tanycytes
(Kakucska et al. 1992; Rodriguez et al. 2005; Fekete and
Lechan 2007). A working hypothesis for future studies is
that increased hypothalamic TRH expression detected in
mice with JNK deficiency in the brain (Sabio and Davis
2010) is mediated by loss of JNK function in tanycytes,
reduced Dio2 expression, and, consequently, reduced T4-
mediated feedback inhibition of neuronal TRH expression.
Conclusions
We identify the Dio2 gene as a key target of the JNK
signaling pathway during the development of obesity.
Consuming a HFD causes JNK activation in the anterior
pituitary gland, increasedDio2 gene expression, decreased
energy expenditure, and the development of obesity.
Disruption of JNK signaling in the anterior pituitary gland
increases energy expenditure and suppresses obesity. To-
gether, these data identify a molecular mechanism that
contributes to JNK-dependent development of obesity in
response to feeding a HFD.
Materials and methods
Mice
We previously described Jnk1LoxP/LoxP mice (Das et al.
2007), Jnk2LoxP/LoxP mice (Han et al. 2013), and Rosa-CreERT
Jnk1LoxP/LoxP Jnk2/ mice (Das et al. 2007). C57BL/6J mice
(stock no. 000664), Rosa-CreERT mice (stock no. 00487) (Badea
et al. 2003), andCga-Cremice (stock no. 004426) (Cushman et al.
2000) were obtained from The Jackson Laboratory. The mice
were backcrossed to the C57BL/6J strain (10 generations) and
housed in a facility accredited by the American Association for
Laboratory Animal Care (AALAC). The mice were genotyped by
PCR analysis of genomic DNA (Das et al. 2007; Han et al. 2013).
All studies were performed using male mice (8–24 wk old). Rosa-
CreERT mice and Rosa-CreERT Jnk1LoxP/LoxP Jnk2/ mice were
treated with 1 mg of tamoxifen (Sigma) by intraperitoneal (i.p.)
injection once each day for five consecutive days. Male mice
(8 wk old) were fed a ND or a HFD (Iso Pro 3000 [Purina] and
F3282 [Bioserve, Inc.]) for 16 wk. Whole-body fat and lean mass
were noninvasively measured using 1H-MRS (Echo Medical
Systems). The animal studies were approved by the Institutional
Animal Care and Use Committee of the University of Massa-
chusetts Medical School.
Primary cell culture
Anterior pituitary cells were established in primary cul-
ture (Koenig et al. 1984). Briefly, pituitaries were removed
from tamoxifen-treated Rosa-CreERT (PWT) and Rosa-CreERT
Jnk1LoxP/LoxP Jnk2/ (PDJ1,J2) male mice (12–16 wk old). The
posterior and intermediate lobes were discarded. The anterior
pituitaries were digested in HBSS containing 1 mg/mL trypsin, 2
mg/mL collagenase, and 1 mg/mL DNase for 30 min at 37°C.
Digested pituitary glands were washed and triturated in DMEM/
F12 supplemented with 10% charcoal-stripped FBS (Invitrogen).
The single-cell suspension was then plated onto poly-D-lysine-
coated 24-well plates (Life Technologies). The cells were har-
vested for analysis after 24 h in culture.
RNA analysis
The expression of mRNA was examined by quantitative PCR
analysis using a Quantstudio PCR machine (Life Technologies).
TaqMan assays were used to quantitate Ccl2 (Mm00441242_m1),
cFos (Mm00487425_m1), cJun (Mm00495062_s1), Cga/Tsha
(Mm01209400_m1),Dio1 (Mm00839358_m1),Dio2 (Mm00515664_m1),
Dio3 (Mm00548953_s1), Emr1 (F4/80) (Mm00802530_m1),
Gata2 (Mm00492301_m1), Glut4 (Mm00436615-m1), Jnk1
(Mm00489514_m1), Jnk2 (Mm00444231_m1), JunB (Mm00492781_s1),
JunD (Mm00495088_s1), Ldhb (Mm00493146_m1), Leptin
(Mm00434759_m1), Pou1f1 (Mm00476852_m1), Slc16a2
(Mm00486204_m1), Spot14 (Mm01273967_m1), Thrb
(Mm00437044_m1), Trh (Mm01963590_s1), Trhr (Mm00443262_m1),
Tshb (Mm00437190_m1), and Tnfa (Mm00443258_m1). The
relative mRNA expression was normalized by measurement of
the amount of 18S RNA in each sample using TaqMan assays
(catalog no. 4308329, Life Technologies).
Immunoblot analysis
Tissue extracts were prepared using Triton lysis buffer (20 mM
Tris at pH 7.4, 1% Triton X-100, 10% glycerol, 137 mM NaCl,
2 mM EDTA, 25 mM b-glycerophosphate, 1 mM sodium
orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 mg/mL
aprotinin and leupeptin). Extracts (20–50 mg of protein) were
examined by protein immunoblot analysis by probing with anti-
bodies to AKT, phospho-Thr308 AKT, and phospho-Ser473 AKT
(Cell Signaling); cJun (Santa Cruz Biotechnology); JNK (Pharmigen);
and aTubulin (Sigma). Immunocomplexes were detected using
the Odyssey infrared imaging system (LI-COR Biosciences).
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Blood analysis
Blood glucose was measured with an Ascensia Breeze 2
glucometer (Bayer). Adipokines, cytokines, pituitary hormones,
and insulin in plasma were measured by multiplexed ELISA
using a Luminex 200 machine (Millipore). T3 and T4 in plasma
were measured using an ELISA kit (Calbiotech). Free T4 was
measured using a kit purchased from Leinco Technologies.
Glucose and insulin tolerance tests
Glucose and insulin tolerance tests were performed by i.p.
injection of mice with 2 g/kg glucose or 0.5 U/kg insulin using
methods described previously (Sabio et al. 2008).
Treatment of mice with thyroid hormone
Mice were treated (16 wk) with PTU in the drinking water
(cherry-flavored Kool-Aid supplemented without [Control] or
with 1.2 mM PTU [Sigma]). The mice were injected i.p. with
saline (solvent control) or thyroid hormone (30 mg/kg T3 or 10
mg/kg T4). The amount of TSH in the blood prior to injection and
at 5 h post-injection was measured by ELISA.
Metabolic cages
The analysis was performed by the Mouse Metabolic Phenotyp-
ing Center at the University of Massachusetts Medical School.
The mice were housed under controlled temperature and light-
ing with free access to food and water. The food/water intake,
energy expenditure, respiratory exchange ratio, and physical
activity were measured using metabolic cages (TSE Systems).
Analysis of tissue sections
Histology was performed using tissue fixed in 10% formalin for
24 h, dehydrated, and embedded in paraffin. Sections (7 mm) were
cut and stained using hematoxylin and eosin (American Master
Tech Scientific). Paraffin sections were stained with an anti-
body to F4/80 (Abcam), insulin (Dako), perilipin (Abcam),
phosphoJNK (Cell Signaling), and TSHb (a gift from Dr. A.
Parlow, National Institute of Diabetes and Digestive and Kidney
Diseases). The primary antibodies were detected by incubation
with anti-guinea pig Ig, anti-rat Ig, or anti-rabbit Ig conjugated to
Alexa Fluor 488 or 633 (Life Technologies). DNAwas detected by
staining with DAPI (Life Technologies). Fluorescence was visu-
alized using a Leica TCS SP2 confocal microscope equipped with
a 405-nm diode laser. Islet area was determined by dividing total
b-cell area (marked by staining with insulin antibodies) by the
pancreatic area per section using ImageJ64 software. Hepatic
steatosis was examined using sections (7 mm) prepared from
tissue frozen in O.C.T. compound (Tissue-Tek) and staining with
Sudan black (American Master Tech Scientific).
Electron microscopy
Transmission electron microscopy was performed using tissue
washed with 0.1 M sodium cacodylate buffer (pH 7.2) and fixed
with 2.5% glutaraldehyde for 30 min at room temperature and in
the same fresh fixative overnight at 4°C. The tissue was rinsed
(10 min) in 0.1 M sodium cacodylate buffer (pH 7.2) three times
and then post-fixed (1 h) in 1% (w/v) osmium tetroxide in
distilled water. The fixed tissue was rinsed in double-distilled
water and dehydrated through a graded ethanol series (10%,
30%, 50%, 70%, 85%, and 95% for 20 min each) before two
changes of ethanol (100%). The samples then were treated with
two changes of propylene oxide and with a propylene oxide/SPI-
Pon 812 resin mixture (1/1). On the following day, three changes
of fresh SPI-Pon 812 resin were performed before the samples
were polymerized at 68°C in flat embedding molds. The epoxy
blocks were cut and mounted on blank epoxy stubs with a drop
of superglue. Ultrathin sections were cut on a Reichart-Jung
ultramicrotome using a diamond knife. The sections were col-
lected and mounted on copper support grids, contrasted with
lead citrate and uranyl acetate, and examined using a FEI Tecnai
12 BT electron microscope with 80 kV accelerating voltage.
Images were captured using a Gatan TEM CCD camera.
Scanning electron microscopy was performed using tissue
fixed as described for transmission electron microscopy and
washed three times in the same fixation buffer. The samples
were then dehydrated through a graded series of ethanol (10%,
30%, 50%, 70%, 85%, and 95% for 20 min each) before two
changes of ethanol (100%) and then critical point-dried in liquid
CO2. The dried samples were mounted onto aluminum stubs
with carbon tape, carbon-coated (10 nm), and then sputter-coated
(8 nm) with Au/Pd (80/20). The specimens were examined using
a FEI Quanta 200 FEG MK II scanning electron microscope at 5
kV accelerating voltage.
Statistical analysis
Differences between groups were examined for statistical signif-
icance using the Student’s test or analysis of variance (ANOVA)
with the Fisher’s test.
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